AbbottABT
A Abbott CompanyDescription
Founded in 1888, Abbott has evolved into a global healthcare leader dedicated to helping people live fuller, healthier lives through innovative technologies and solutions. Headquartered in Abbott Park, Illinois, the company employs over 114,000 professionals serving people in more than 160 countries worldwide. Abbott's comprehensive portfolio spans the healthcare spectrum, encompassing leading businesses in diagnostics, medical devices, nutritional products, and branded generic medicines.
At Abbott, employees contribute to meaningful work that directly impacts patients' lives. The company's mission to revolutionize healthcare through personal technologies empowers individuals with the data and knowledge needed to live longer and better. This patient-centered approach has established Abbott as a trusted name in the healthcare industry, with a significant presence on social media platforms and over 3.8 million LinkedIn followers.
The company offers diverse career opportunities across multiple locations throughout the United States, including Illinois, California, Minnesota, Texas, Ohio, and Massachusetts. Abbott's workplace culture emphasizes innovation, collaboration, and professional growth, providing employees with competitive benefits and development opportunities within a global community.
Abbott continues to shape the future of healthcare by creating life-changing technologies that help identify medical needs quickly, treat conditions effectively, and support overall wellness. For professionals seeking to make a difference in healthcare, Abbott offers the chance to join a forward-thinking organization committed to addressing global health challenges through science, technology, and compassionate care.
Offices
Latest News
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a new treatment option for patients who are not candidates for open-heart surgery or mitral repair This approval expands Abbott's portfolio of minimally invasive structural heart therapies in the U.S. ABBOTT PARK, Ill., May 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S....
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes. 1 This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors. 1 Results also show a reduction in hospitalization for cardiovascular complications in adults with Type 2 diabetes on insulin using Libre technology. 2 ABBOTT PARK, Ill., May 15, 2025 /PRNewswire/ --...
Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent
This summer, Abbott and Real Madrid are hosting tryouts across the U.S. to form the 'Abbott Dream Team' Tryout attendees will learn about health and sports nutrition, encouraging them to promote healthy habits and an active lifestyle in their communities Eleven selected players will travel to Madrid, train at Real Madrid's world-class facilities, and be instructed by Real Madrid coaches American soccer icon Clint Dempsey will mentor the athletes throughout their journey ABBOTT PARK, Ill., May...
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
The test, run on Abbott's portable i-STAT ® Alinity ® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes The test will be used by healthcare professionals in the medical facilities at all MotoAmerica races in 2025 ABBOTT PARK, Ill., and IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare company, and MotoAmerica, the...
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
Collaboration brings together FreeStyle Libre ® Systems, the world's leading continuous glucose monitoring technology (CGM) 1 with Epic, a healthcare software company, to streamline access to CGM data for healthcare organizations Integration empowers U.S. clinicians to enhance patient care by incorporating Libre's data directly into their workflows ABBOTT PARK, Ill., April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable...